180 related articles for article (PubMed ID: 18839283)
41. Simple way to obtain pH-sensitive drug release from functional mesoporous silica materials.
Xiang D; Lin H; Guo W; Ma J; Cui L; Jiang J; Qu F
IET Nanobiotechnol; 2014 Dec; 8(4):179-83. PubMed ID: 25429494
[TBL] [Abstract][Full Text] [Related]
42. Evaluation of ordered mesoporous silica as a carrier for poorly soluble drugs: influence of pressure on the structure and drug release.
Vialpando M; Aerts A; Persoons J; Martens J; Van Den Mooter G
J Pharm Sci; 2011 Aug; 100(8):3411-3420. PubMed ID: 21387318
[TBL] [Abstract][Full Text] [Related]
43. Fabrication of mesoporous silica shells on solid silica spheres using anionic surfactants and their potential application in controlling drug release.
El-Toni AM; Khan A; Ibrahim MA; Al-Hoshan M; Labis JP
Molecules; 2012 Nov; 17(11):13199-210. PubMed ID: 23132137
[TBL] [Abstract][Full Text] [Related]
44. Drug delivery from ordered mesoporous matrices.
Manzano M; Colilla M; Vallet-Regí M
Expert Opin Drug Deliv; 2009 Dec; 6(12):1383-400. PubMed ID: 19941412
[TBL] [Abstract][Full Text] [Related]
45. Development of insulin loaded mesoporous silica injectable particles layered by chitosan as a controlled release delivery system.
Elsayed A; Al-Remawi M; Maghrabi I; Hamaidi M; Jaber N
Int J Pharm; 2014 Jan; 461(1-2):448-58. PubMed ID: 24368103
[TBL] [Abstract][Full Text] [Related]
46. Metalloporphyrins immobilized in Fe3O4@SiO2 mesoporous submicrospheres: Reusable biomimetic catalysts for hydrocarbon oxidation.
Barbosa IA; de Sousa Filho PC; da Silva DL; Zanardi FB; Zanatta LD; de Oliveira AJA; Serra OA; Iamamoto Y
J Colloid Interface Sci; 2016 May; 469():296-309. PubMed ID: 26897566
[TBL] [Abstract][Full Text] [Related]
47. Preparation of magnetite-loaded silica microspheres for solid-phase extraction of genomic DNA from soy-based foodstuffs.
Shi R; Wang Y; Hu Y; Chen L; Wan QH
J Chromatogr A; 2009 Sep; 1216(36):6382-6. PubMed ID: 19632684
[TBL] [Abstract][Full Text] [Related]
48. Silver nanoparticle gated, mesoporous silica coated gold nanorods (AuNR@MS@AgNPs): low premature release and multifunctional cancer theranostic platform.
Zhang Z; Liu C; Bai J; Wu C; Xiao Y; Li Y; Zheng J; Yang R; Tan W
ACS Appl Mater Interfaces; 2015 Mar; 7(11):6211-9. PubMed ID: 25707533
[TBL] [Abstract][Full Text] [Related]
49. A stand-alone mesoporous crystal structure model from in situ X-ray diffraction: nitrogen adsorption on 3D cagelike mesoporous silica SBA-16.
Miyasaka K; Hano H; Kubota Y; Lin Y; Ryoo R; Takata M; Kitagawa S; Neimark AV; Terasaki O
Chemistry; 2012 Aug; 18(33):10300-11. PubMed ID: 22829334
[TBL] [Abstract][Full Text] [Related]
50. Preparation and physical characterization of calcium sulfate cement/silica-based mesoporous material composites for controlled release of BMP-2.
Tan H; Yang S; Dai P; Li W; Yue B
Int J Nanomedicine; 2015; 10():4341-50. PubMed ID: 26185438
[TBL] [Abstract][Full Text] [Related]
51. Mesoporous silicas templated by heterocyclic amino acid derivatives: Biomimetic synthesis and drug release application.
Li H; Ke J; Li H; Wei C; Wu X; Li J; Yang Y; Xu L; Liu H; Li S; Yang M; Wei M
Mater Sci Eng C Mater Biol Appl; 2018 Dec; 93():407-418. PubMed ID: 30274073
[TBL] [Abstract][Full Text] [Related]
52. Magnetic-sensitive silica nanospheres for controlled drug release.
Hu SH; Liu TY; Huang HY; Liu DM; Chen SY
Langmuir; 2008 Jan; 24(1):239-44. PubMed ID: 18052081
[TBL] [Abstract][Full Text] [Related]
53. Mesoporous silica nanoparticles capped with disulfide-linked PEG gatekeepers for glutathione-mediated controlled release.
Cui Y; Dong H; Cai X; Wang D; Li Y
ACS Appl Mater Interfaces; 2012 Jun; 4(6):3177-83. PubMed ID: 22646097
[TBL] [Abstract][Full Text] [Related]
54. Synthesis and surface modification of mesoporous silica nanoparticles and its application as carriers for sustained drug delivery.
Ahmadi E; Dehghannejad N; Hashemikia S; Ghasemnejad M; Tabebordbar H
Drug Deliv; 2014 May; 21(3):164-72. PubMed ID: 24116869
[TBL] [Abstract][Full Text] [Related]
55. Drug loaded and ethylcellulose coated mesoporous silica for controlled drug release prepared using a pilot scale fluid bed system.
Hacene YC; Singh A; Van den Mooter G
Int J Pharm; 2016 Jun; 506(1-2):138-47. PubMed ID: 27107901
[TBL] [Abstract][Full Text] [Related]
56. Inclusion of fenofibrate in a series of mesoporous silicas using microwave irradiation.
Waters LJ; Hussain T; Parkes G; Hanrahan JP; Tobin JM
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):936-41. PubMed ID: 23954510
[TBL] [Abstract][Full Text] [Related]
57. Ordered mesoporous polymer-silica hybrid nanoparticles as vehicles for the intracellular controlled release of macromolecules.
Kim TW; Slowing II; Chung PW; Lin VS
ACS Nano; 2011 Jan; 5(1):360-6. PubMed ID: 21162552
[TBL] [Abstract][Full Text] [Related]
58. Molecular organization of hydrophobic molecules and co-adsorbed water in SBA-15 ordered mesoporous silica material.
Mellaerts R; Roeffaers MB; Houthoofd K; Van Speybroeck M; De Cremer G; Jammaer JA; Van den Mooter G; Augustijns P; Hofkens J; Martens JA
Phys Chem Chem Phys; 2011 Feb; 13(7):2706-13. PubMed ID: 21152589
[TBL] [Abstract][Full Text] [Related]
59. A focal adhesion kinase inhibitor 16-hydroxy-cleroda-3,13-dien-16,15-olide incorporated into enteric-coated nanoparticles for controlled anti-glioma drug delivery.
Thiyagarajan V; Lin SX; Lee CH; Weng CF
Colloids Surf B Biointerfaces; 2016 May; 141():120-131. PubMed ID: 26851441
[TBL] [Abstract][Full Text] [Related]
60. Natural polymer-based magnetic hydrogels: Potential vectors for remote-controlled drug release.
Paulino AT; Pereira AG; Fajardo AR; Erickson K; Kipper MJ; Muniz EC; Belfiore LA; Tambourgi EB
Carbohydr Polym; 2012 Oct; 90(3):1216-25. PubMed ID: 22939334
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
